Antiemetic Drugs Market by Type (Acetylcholine, Anticholinergics, Antihistamines), Application (Chemotherapy, Post Operative Surgery, Pregnancy), Sales Channel - Global Forecast 2024-2030
The Antiemetic Drugs Market size was estimated at USD 6.01 billion in 2023 and expected to reach USD 5.92 billion in 2024, at a CAGR 7.21% to reach USD 9.79 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antiemetic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antiemetic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antiemetic Drugs Market, highlighting leading vendors and their innovative profiles. These include Acacia Pharma Limited, Akorn Operating Company LLC, Algen Healthcare Ltd., Alkem Laboratories Ltd., Cipla Limited, Dr. Reddy's Laboratories Limited, Fresenius Kabi Pte Ltd., Glenmark Pharmaceuticals Limited, Global Calcium Private Limited, Helsinn Healthcare S.A., Hikma Pharmaceuticals PLC, Lupin Limited, Merck KGaA, Novartis AG, Pax Healthcare, Pfizer Inc., Sanofi S.A., Saphnix Life Sciences, Scindia Pharma, Sun Pharmaceutical Industries Limited, Swastik Life Sciences, Teva Pharmaceuticals Industries Ltd., Torrent Pharmaceuticals Ltd., Viatris Inc., and Weefsel Pharma.
Market Segmentation & Coverage
This research report categorizes the Antiemetic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Acetylcholine
Chemotherapy
Offline
Hospitals Pharmacies
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Antiemetic Drugs Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antiemetic Drugs Market?
- What are the technology trends and regulatory frameworks in the Antiemetic Drugs Market?
- What is the market share of the leading vendors in the Antiemetic Drugs Market?
- Which modes and strategic moves are suitable for entering the Antiemetic Drugs Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Antiemetic Drugs Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of gastroenteritis, vomiting and nausea associated diseases
- 5.1.1.2. Increasing prevalence of cancer and gastroenteritis worldwide
- 5.1.2. Restraints
- 5.1.2.1. Less knowledge regarding the appropriate dosage and usage of anti-emetic drugs
- 5.1.3. Opportunities
- 5.1.3.1. Rising research and development to introduce new anti-emetic drugs
- 5.1.3.2. Increase in healthcare investments and rising research and development activities
- 5.1.4. Challenges
- 5.1.4.1. Capital intensive and time consuming process associated with anti-emetic drugs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Antiemetic Drugs Market, by Type
- 6.1. Introduction
- 6.2. Acetylcholine
- 6.3. Anticholinergics
- 6.4. Antihistamines
- 6.5. Dopamine Receptor Antagonists
- 6.6. Neurokinin Receptor Antagonists
- 6.7. Serotonin Receptor Antagonists
- 7. Antiemetic Drugs Market, by Application
- 7.1. Introduction
- 7.2. Chemotherapy
- 7.3. Post Operative Surgery
- 7.4. Pregnancy
- 8. Antiemetic Drugs Market, by Sales Channel
- 8.1. Introduction
- 8.2. Offline
- 8.3.1. Hospitals Pharmacies
- 8.3.2. Retail Pharmacies
- 8.3. Online
- 9. Americas Antiemetic Drugs Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Antiemetic Drugs Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Antiemetic Drugs Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Acacia Pharma Limited
- 13.1.2. Akorn Operating Company LLC
- 13.1.3. Algen Healthcare Ltd.
- 13.1.4. Alkem Laboratories Ltd.
- 13.1.5. Cipla Limited
- 13.1.6. Dr. Reddy's Laboratories Limited
- 13.1.7. Fresenius Kabi Pte Ltd.
- 13.1.8. Glenmark Pharmaceuticals Limited
- 13.1.9. Global Calcium Private Limited
- 13.1.10. Helsinn Healthcare S.A.
- 13.1.11. Hikma Pharmaceuticals PLC
- 13.1.12. Lupin Limited
- 13.1.13. Merck KGaA
- 13.1.14. Novartis AG
- 13.1.15. Pax Healthcare
- 13.1.16. Pfizer Inc.
- 13.1.17. Sanofi S.A.
- 13.1.18. Saphnix Life Sciences
- 13.1.19. Scindia Pharma
- 13.1.20. Sun Pharmaceutical Industries Limited
- 13.1.21. Swastik Life Sciences
- 13.1.22. Teva Pharmaceuticals Industries Ltd.
- 13.1.23. Torrent Pharmaceuticals Ltd.
- 13.1.24. Viatris Inc.
- 13.1.25. Weefsel Pharma
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ANTIEMETIC DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. ANTIEMETIC DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANTIEMETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANTIEMETIC DRUGS MARKET DYNAMICS
- FIGURE 7. ANTIEMETIC DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ANTIEMETIC DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANTIEMETIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. ANTIEMETIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANTIEMETIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. ANTIEMETIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ANTIEMETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ANTIEMETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook